Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Pharma Guide

To find a commercial service, choose an option from the Main Category below or Search by Company Name.

Pipeline Monitor
Gilead scores first win from Kite buyout
Gilead has received its first FDA approval for newly acquired CAR-T Yescarta following its USD12 billion buyout of original sponsor Kite Pharma in August.
Perspective
Pharma risks made crystal clear
Once in a while the size of the financial risks inherent in the drug business is made clear and the price of failure emerges as very significant.
Approvals Action
Generics target HIV combo
Generic company Lupin has registered additional competitors for ViiV's HIV combination therapy Kivexa signalling increasing interest in its forhcoming patent expiry.